Suraksha Diagnostic Limited (NSE:SURAKSHA)
India
· Delayed Price · Currency is INR 325.05
-7.70 (-2.31%)
Jun 12, 2025, 3:29 PM IST
Suraksha Diagnostic Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Net Income | 318.24 | 236.26 | 65.16 | 208.24 | 64.35 |
| Depreciation & Amortization | 352.98 | 321.96 | 313.06 | 278.13 | 147.46 |
| Other Amortization | - | 4.02 | 3.65 | 5.82 | 9.66 |
| Loss (Gain) From Sale of Assets | 2.56 | 21.45 | 24.33 | 14.15 | 24.5 |
| Asset Writedown & Restructuring Costs | - | 7.79 | - | - | - |
| Loss (Gain) From Sale of Investments | - | - | - | - | -2.94 |
| Stock-Based Compensation | 2.11 | - | - | - | - |
| Provision & Write-off of Bad Debts | 24.54 | 5.36 | - | 0.72 | 28.44 |
| Other Operating Activities | 36.43 | 44.87 | -13.53 | 107.01 | -9.53 |
| Change in Accounts Receivable | -72.12 | -47.29 | 24.82 | -15.71 | -28.44 |
| Change in Inventory | -13.71 | -5.16 | 0.63 | -17.81 | 10.01 |
| Change in Accounts Payable | -5.19 | 3.54 | 4.81 | 16.51 | -3.31 |
| Change in Other Net Operating Assets | -12.24 | 12.04 | 18.03 | -18.83 | -5.09 |
| Operating Cash Flow | 633.59 | 604.84 | 440.96 | 578.23 | 235.12 |
| Operating Cash Flow Growth | 4.75% | 37.16% | -23.74% | 145.93% | - |
| Capital Expenditures | -420.24 | -446.94 | -131.67 | -192.49 | -154.01 |
| Sale of Property, Plant & Equipment | 1.41 | 17.73 | 6.61 | 3.44 | 2.5 |
| Cash Acquisitions | - | - | - | - | -33.6 |
| Investment in Securities | -12.6 | 47.35 | -108.26 | -260.93 | -98.09 |
| Other Investing Activities | 35.59 | 31.9 | 25.37 | 17.17 | 6.11 |
| Investing Cash Flow | -395.84 | -349.96 | -207.95 | -432.81 | -277.08 |
| Long-Term Debt Issued | - | 5 | 20.5 | 95.91 | 48.31 |
| Long-Term Debt Repaid | -235.12 | -254.25 | -250.82 | -223.74 | - |
| Net Debt Issued (Repaid) | -235.12 | -249.25 | -230.32 | -127.83 | 48.31 |
| Other Financing Activities | -5.37 | -2.05 | -12.96 | -15.02 | -16.2 |
| Financing Cash Flow | -240.48 | -251.3 | -243.28 | -142.85 | 32.11 |
| Net Cash Flow | -2.73 | 3.58 | -10.27 | 2.57 | -9.86 |
| Free Cash Flow | 213.35 | 157.9 | 309.29 | 385.74 | 81.11 |
| Free Cash Flow Growth | 35.12% | -48.95% | -19.82% | 375.57% | - |
| Free Cash Flow Margin | 8.34% | 7.22% | 16.27% | 17.28% | 5.79% |
| Free Cash Flow Per Share | 4.00 | 2.96 | 5.80 | 7.24 | 1.52 |
| Cash Interest Paid | 6.37 | 9.08 | 12.96 | 15.02 | 16.2 |
| Cash Income Tax Paid | 105.82 | 86.1 | 71.93 | 27.96 | 15.03 |
| Levered Free Cash Flow | 146.11 | 53.51 | 270.18 | 287.95 | - |
| Unlevered Free Cash Flow | 198.52 | 108.44 | 326.8 | 343.23 | - |
| Change in Net Working Capital | 61.18 | 18.19 | -49.97 | -28.66 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.